Akebia Therapeutics (AKBA) Revenue (2017 - 2026)
Akebia Therapeutics (AKBA) recorded Revenue of $49.13 million in Q2 2026, down 21.4% from $62.47 million a year earlier and down 8.2% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Revenue (2017 - 2026) Analysis & Trends
On a TTM basis, Akebia Therapeutics' Revenue came in at $219.06 million as of Jun 30, 2026, up 7.5% year-over-year; for FY2025, it was $236.2 million, up 47.5% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $160.18 million in FY2024 (-17.7%), $194.62 million in FY2023 (-33.5%), $292.48 million in FY2022 (+38.2%) and $211.65 million in FY2021 (-28.2%).
- The Q2 2026 figure is the lowest quarterly Revenue since Q4 2024.
- On a year-over-year basis, Revenue rose in four of the last eight quarters, with growth averaging 18.0%.
- Peak year-over-year performance for Revenue in the last five years was growth of 138.8% in Q2 2022, against a decline of 55.4% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $53.54 million (Q1 2026), $57.62 million (Q4 2025) and $58.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn | 49.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.13 Mn |
| Mar 31, 2026 | 53.54 Mn |
| Dec 31, 2025 | 57.62 Mn |
| Sep 30, 2025 | 58.77 Mn |
| Jun 30, 2025 | 62.47 Mn |
| Mar 31, 2025 | 57.34 Mn |
| Dec 31, 2024 | 46.50 Mn |
| Sep 30, 2024 | 37.43 Mn |
| Jun 30, 2024 | 43.65 Mn |
| Mar 31, 2024 | 32.61 Mn |
| Dec 31, 2023 | 56.20 Mn |
| Sep 30, 2023 | 42.05 Mn |
| Jun 30, 2023 | 56.38 Mn |
| Mar 31, 2023 | 40.01 Mn |
| Dec 31, 2022 | 55.78 Mn |
| Sep 30, 2022 | 48.71 Mn |
| Jun 30, 2022 | 126.37 Mn |
| Mar 31, 2022 | 61.70 Mn |
| Dec 31, 2021 | 57.68 Mn |
| Sep 30, 2021 | 48.76 Mn |
API Access
Akebia Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();